ReviewFrontiers in rehabilitation sciences2026
Pathological similarities between degenerative enthesopathy and rheumatic enthesitis: the role of ECM stiffness and Wolff's Law-based mechanical stimulation as a therapeutic strategy.
Review in Frontiers in rehabilitation sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Degenerative enthesopathy and rheumatic enthesitis have traditionally been regarded as distinct disorders driven by mechanical overload and immune dysregulation, respectively. However, increasing evidence suggests that the mechanobiological links between these conditions have been underappreciated. In particular, pathological stiffening of the extracellular matrix (ECM) at the enthesis has emerged as a potential common mechanism connecting cumulative mechanical loading, chronic low-grade inflammation, and dysregulated mechanotransduction. This review synthesizes current biomechanical and immunological evidence linking ECM rigidity to fibrocartilage metaplasia, bone marrow edema, and pathological neo-osteogenesis. Histopathological similarities between degenerative and inflammatory phenotypes, including subperiosteal fibrosis, advancing mineralization fronts, and immune-cell trafficking through transcortical vessels (TCVs), further support the concept of a shared disease continuum. ECM stiffness may represent a shared mechanobiological feature contributing to structural degeneration, chronic inflammation, and aberrant ossification in both conditions. We further examine the therapeutic potential of Wolff's Law-based mechanical stimulation strategies, including dry needling, vibration therapy, and targeted mechanical stimulation of periosteal and entheseal regions. These interventions engage mechanosensitive pathways that may restore matrix compliance, improve microvascular perfusion, and modulate inflammatory activity within the enthesis microenvironment. Taken together, the available evidence indicates that ECM stiffness is not only a marker of disease progression but also a plausible therapeutic target. This perspective may inform future stiffness-oriented treatment strategies, including bio-electric stimulation-based approaches, for restoring enthesis homeostasis in both degenerative and rheumatic disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.